Safety II Together: Coupling teaming science with patient engagement and health information transparency to coproduce diagnostic excellence
Safety II Together: Coupling teaming science with patient engagement and health information transparency to coproduce diagnostic excellence
批准号:
10849649
负责人:
SIGALL BELL
金额:
$96.68万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-30 至 2026-09-29
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Ambulatory diagnostic error is a vexing problem because events unfold across time with shifting team
members. Accurate and timely diagnosis relies on keeping patients and health care professionals (HCPs) on
the same page, both in and between clinic visits. Experts urge shared mental models (SMMs) of the diagnostic
process (DxP), because research shows their central role for effective team communication and coordination.
Yet little is known about how patients and HCPs develop and sustain SMMs, especially in the dynamic setting
of the DxP. While we have many examples of diagnostic errors in Safety-I research, there are few models of
“what good looks like” using a Safety-II lens. Since diagnostic excellence relies on factors and interactions
beyond any single HCP, progress will require identifying specific teaming behaviors that help patients and
HCPs to coproduce safety at known DxP risk points. We will close this foundational knowledge gap. We will
then develop and disseminate tools to support patients, care partners, interpreters and clinicians as active
contributors to the DxP through 3 partnering national organizations. In our current AHRQ grant, we learned that
patients have unique insights about the DxP, including identification of “diagnostic blindspots” – events or
conditions pertaining to DxP safety that HCPs or systems may not observe. These include events occurring
between visits, omissions, and misalignments stemming from lack of a SMM between patients and HCPs.
Interestingly, online access to visit notes (“open notes”) – now nearly universal through 2021 federal legislation
– may help development of SMMs because patients can gain context on HCP perspectives and potential gaps
in their understanding by reading notes. One sobering finding was that the most common contributing factor to
patient-reported diagnostic error was not feeling heard. Based on these data, we designed an online tool –
OurDX – to elicit patient priorities, histories, and potential concerns. We found that patients with limited English
proficiency (LEP) were 5x as likely to report not feeling heard, and older patients with poorer health were more
likely to identify a diagnostic blindspot. Teams that work need new approaches to share information, to listen,
and to respond, especially since harnessing the unique knowledge of each member (including early
identification of otherwise undetected blindspots) can increase system resilience. Our diagnostic center of
excellence – Safety2gether – is based on innovative and disciplined coupling of teaming science with patient
engagement to coproduce diagnostic safety, with a focus on safety-II principles and priority populations: LEP
and elderly patients with chronic illness and their care partners. Safety2gether will partner with patients, train
learners, define future research questions, foster collaborations, and share multistakeholder tools through 3
national organizations to both learn from, and serve as a resource for, other DCEs. Our team is specifically
curated with over a decade of expertise in teaming, diagnostic safety and patient engagement, and is uniquely
poised to help build safety equity through an evidence-based emphasis on listening and resilience.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Safety II Together: Coupling teaming science with patient engagement and health information transparency to coproduce diagnostic excellence
-
批准号:10642466
-
项目类别:
-
资助金额:$95.74万
-
财政年份:2022
-
负责人:SIGALL BELL
-
依托单位:
Answering the call to engage patients and families in the diagnostic process: A new patient-centered approach using health information transparency to identify diagnostic breakdowns in ambulatory care
-
批准号:10254283
-
项目类别:
-
资助金额:$48.89万
-
财政年份:2019
-
负责人:SIGALL BELL
-
依托单位:
Answering the call to engage patients and families in the diagnostic process: A new patient-centered approach using health information transparency to identify diagnostic breakdowns in ambulatory care
-
批准号:10016291
-
项目类别:
-
资助金额:$49.42万
-
财政年份:2019
-
负责人:SIGALL BELL
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于生境成像与深度学习联合临床特征构建II型卵巢癌术前淋巴结转移预测模型的研究
-
批准号:2026JJ81984
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨石平
-
依托单位:
鸡软骨非变性II型胶原高效制备和靶向递送的关键技术开发与应用示范
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:赵子方
-
依托单位:
青蒿琥酯协同TROP2/线粒体级联靶向的NIR-II多模态诊疗用于晚期TNBC精准诊断与治疗的机制研究
-
批准号:2026JJ30126
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨沙
-
依托单位:
苏合颗粒治疗慢性萎缩性胃炎的临床(II期)评价关键技术研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:蒋晓波
-
依托单位:
医工融合策略下的新型NIR-II有机探针用于中晚期肝癌精准诊断与协同治疗
-
批准号:2026JJ30093
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈国栋
-
依托单位:
用于肺纤维化实时动态监测的NIR-II稀土纳米探针研究
-
批准号:JCZRLH202600246
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
以数据与知识双驱动的NIR-II荧光成像智能分析新范式与基础算法
-
批准号:JCZRMS202600521
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
桥粒斑蛋白调控II型肺泡上皮细胞凋亡易感性而促进特发性肺纤维化形成的机制研究
-
批准号:2026JJ70015
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:彭菲
-
依托单位:
光敏型钌(II)配合物与喜树碱协同给药抗肝癌活性及作用机制研究
-
批准号:2026JJ81924
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谷依盈
-
依托单位:
草鱼免疫球蛋白与GCRV-II互作机制及高效疫苗创制
-
批准号:JCZRQNA202600094
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位: